Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Audited financial results of the Company for the year ended March 31 2026 (both Standalone & Consolidated) and declaration of Interim Dividend if any for the FY 2025-26